U.S. Markets open in 6 hrs 26 mins

Sparks Therapeutics' gene therapy treatment for blindness...

CNBC's Meg Tirrell reports Sparks Therapeutics could be the first biotech company in the U.S. to get approval from the FDA to treat a rare form of blindness at its genetic root.